Skip to main content

Table 2 Demographics of de-identified patients enrolled in this study

From: Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma

EGFR

Age-ranges (years)

Pathologic subtype

TNM stage

Smoking

L858R mutation

50–60

adenocarcinoma

IV

0

L858R mutation

50–60

adenocarcinoma

IV

300, 30

L858R mutation

70–80

adenocarcinoma

IB

0

L858R mutation

70–80

adenocarcinoma

IV

0

L858R mutation

70–80

adenocarcinoma

IV

1600, 10

L858R mutation

70–80

adenocarcinoma

IB

0

L858R mutation

70–80

adenocarcinoma

IV

450

L858R mutation

60–70

adenocarcinoma

IV

200

L858R mutation

60–70

adenocarcinoma

IV

0

L858R mutation

60–70

adenocarcinoma

IV

0

L858R mutation

50–60

adenocarcinoma

IV

0

L858R mutation

60–70

adenocarcinoma

IV

0

L858R mutation

50–60

adenocarcinoma

IV

0

L858R mutation

80–90

adenocarcinoma

IV

0

L858R mutation

60–70

adenocarcinoma

IV

0

L858R mutation

70–80

adenocarcinoma

IV

0

L858R mutation

40–50

adenocarcinoma

IIA

0

L858R mutation

50–60

adenocarcinoma

IV

0

L858R mutation

60–70

adenocarcinoma

IV

0

L858R mutation

60–70

adenocarcinoma

IV

0

Exon 19 deletion

30–50

adenocarcinoma

IIIB

100

Exon 19 deletion

50–60

adenocarcinoma

IV

0

Exon 19 deletion

60–70

adenocarcinoma

IV

0

Exon 19 deletion

40–50

adenocarcinoma

p-IIIB

0

Exon 19 deletion

50–60

adenocarcinoma

IV

450, 10

Exon 19 deletion

50–60

adenocarcinoma

IV

0

Exon 19 deletion

60–70

adenocarcinoma

IV

300

Exon 19 deletion

60–70

non-small cell lung cancer

IV

140

Exon 19 deletion

60–70

adenocarcinoma

IV

800

Exon 19 deletion

70–80

adenocarcinoma

IV

0

Exon 19 deletion

80–90

adenocarcinoma

IV

0

Exon 19 deletion

60–70

adenocarcinoma

IV

0

Exon 19 deletion

60–70

adenocarcinoma

IV

0

Exon 19 deletion

50–60

adenocarcinoma

IV

0

Exon 19 deletion

70–80

adenocarcinoma

IV

0

Exon 19 deletion

60–70

adenocarcinoma

IV

800, 1

Exon 19 deletion

70–80

adenocarcinoma

IV

1800

Exon 19 deletion

60–70

adenocarcinoma

IV

0

Exon 19 deletion

60–70

adenocarcinoma

cT4N3Mx

0

Exon 19 deletion

40–50

adenocarcinoma

IV

0

Exon 19 deletion

40–50

adenocarcinoma

IV

200

Wild type

60–70

adenocarcinoma

IV

600

Wild type

60–70

adenocarcinoma

IV

2400

Wild type

50–60

mediastinal malignant tumor

?

600

Wild type

60–70

non-small cell lung cancer

IIIB

0

Wild type

50–60

adenocarcinoma

IV

600

Wild type

60–70

small cell lung cancer

IIIB

1000

Wild type

50–60

non-small cell lung cancer

IIIA

0

Wild type

60–70

adenocarcinoma

IV

800

Wild type

60–70

adenocarcinoma

p-IIA

800, 7

Wild type

60–70

small cell lung cancer

IV

800

Wild type

60–70

squamous cell carcinoma

cT4N2Mx

0

Wild type

60–70

small cell lung cancer

IV

0

Wild type

70–80

adenocarcinoma

IIIB

0

Wild type

60–70

non-small cell lung cancer

IIIB

1600

Wild type

60–70

non-small cell lung cancer

cT3N3Mx

1200

Wild type

60–70

adenocarcinoma

IIB

1600, 2

Wild type

60–70

neuroendocrine carcinoma

IV

800

Wild type

70–80

squamous cell carcinoma

IIIA

1200

Wild type

60–70

adenocarcinoma

IV

1200

Wild type

50–60

non-small cell lung cancer

IV

0

  1. *(cigarettes/year), Years after quitting